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Background: Environmental toxins are suspected to play a role in the pathogenesis of amyotrophic lateral sclerosis
(ALS). In an attempt to determine which pathways these toxins can use to enter motor neurons we compared the
distribution of mercury in the CNS of a human and of mice that had been exposed to inorganic mercury.
Results: In the human who had been exposed to metallic mercury, mercury was seen predominantly in the locus
ceruleus and corticomotor neurons, as well as in scattered glial cells. In mice that had been exposed to mercury
vapor or mercuric chloride, mercury was present in lower motor neurons in the spinal cord and brain stem.
Conclusions: In humans, inorganic mercury can be taken up predominantly by corticomotor neurons, possibly
when the locus ceruleus is upregulated by stress. This toxin uptake into corticomotor neurons is in accord with the
hypothesis that ALS originates in these upper motor neurons. In mice, inorganic mercury is taken up predominantly
by lower motor neurons. The routes toxins use to enter motor neurons depends on the nature of the toxin, the
duration of exposure, and possibly the amount of stress (for upper motor neuron uptake) and exercise (for lower
motor neuron uptake) at the time of toxin exposure.
Keywords: Amyotrophic lateral sclerosis, Motor neuron disease, Mercury, Neurotoxin, Corticomotor neuron, Locus
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The cause of sporadic amyotrophic lateral sclerosis
(SALS) remains unknown [1]. Debate continues as to
whether SALS is due to rare gene mutations (either
germline or somatic), or is due to gene-environment in-
teractions that involve toxins or viruses. Of note in this
regard, in a recent study 11% of SALS patients had mu-
tations in one of 6 known ALS genes, compared to 67%
of familial ALS (FALS) patients [2]. If this FALS-SALS
percentage ratio were to remain the same when 100% of
FALS-causing mutations are discovered, by extrapolation
only 16% of SALS patients will harbour ALS-causing
mutations. That leaves 84% of SALS patients whose dis-
ease needs to be explained by some other mechanism.
The percentage of patients with true SALS may be even
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distribution, and reproduction in any mediumALS in distant relatives (who are then considered to be
members of FALS kindreds) may be by chance [3]. One
meta-analysis arrived at a figure for FALS of 5% of total
ALS patients, while another (which divided FALS into
definite, probable and possible categories) indicated that
FALS due to penetrant mutations is likely to represent
no more than 10% of total ALS patients [4].
An environmental toxin that enters motor neurons se-
lectively, and then either alone, or in combination with
some genetic susceptibility to the toxin, destroys the motor
neuron could underlie SALS [5]. Heavy metals in particular
have been suspected to be involved in ALS [6]. However,
despite a plethora of epidemiological, experimental and
pathological studies, evidence to back this hypothesis has
been hard to come by. Some support comes from studies
showing that neurotoxins given systemically to animals lo-
calise preferentially to motor neurons [7], that certain oc-
cupations appear to be associated with an increased risk of
SALS [8], and that gene-environment interactions involv-
ing neurotoxins may underlie some cases of SALS [9]. AMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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sue is that by the time of death most motor neurons in
SALS have disappeared and thus are not available for
examination. Furthermore, the few remaining SALS motor
neurons may still be present because they did not take up
the toxin in the first place, a so-called a “survivor” effect.
Conversely, damaged motor neurons may take up metals
secondarily to the disease process and so confuse the issue
[10]. At present only a few toxins (all of them heavy
metals) can be identified histologically [11]. Finally, it is
rare to obtain CNS tissue for histological examination from
humans who have been exposed to known toxins. For ex-
ample, there are only three previous reports of humans ex-
posed to inorganic mercury whose CNS tissue has been
studied with modern histological techniques [12-14].
In 1996 we reported the distribution of mercury in the
CNS of a man who injected himself with metallic mercury
and who then committed suicide shortly afterwards [14].
At post mortem, mercury deposits were found in a number
of sites in the CNS, particularly in corticomotor neurons
(CMNs). However, no explanation for this CMN uptake of
mercury was offered. The mercury-detection technique
used in this study was autometallography (AMG) [15], and
sections were kept in the staining reagents for varying
lengths of time to demonstrate the mercury grains better
in cells where mercury concentrations were low. This
meant, however, that comparisons between the amount of
mercury in different neurons could not be made. We have
now undertaken three further investigations using tissue
from this mercury-exposed human, as well as tissue from
mercury-exposed mice, in an attempt to gain further in-
sights into the relationship between toxins and ALS.
(1) We have re-stained tissue from the mercury-exposed
human, using a standardised AMG protocol that enables
us to determine which neurons take up the mercury most
avidly. From the distribution of these mercury-containing
neurons we suggest a pathway via the locus ceruleus (LC)
that circulating mercury may use to enter CMNs, and
propose that this uptake may be upregulated by stress.
(2) There has been much interest in the role of glia in
ALS [16], as well as in the role astrocytes play in mer-
cury CNS toxicity [17]. Although glial uptake of mercury
was noted in passing in our previous report [14], the dis-
tribution of mercury-containing glia in the brain was not
studied. We have therefore mapped the regions of the
brain in which glial uptake of mercury was present in an
attempt to assess the role of mercury-containing glia in
motor neuron damage.
(3) Differences between the uptake of inorganic mercury
in humans and rodents has previously been noted, with ro-
dents having prominent lower motor neuron (LMN), but
negligible CMN and glial uptake of this toxin. No direct
comparisons between human and rodent uptake of inor-
ganic mercury have however been undertaken. We havetherefore re-stained tissue from mercury-exposed mice
and compared the distribution of mercury in these mice
with mercury-exposed human tissue. This has enabled us
to outline different pathways that neurotoxins such as mer-
cury may use to enter motor neurons. We propose that
these different routes of toxin uptake into CMNs and
LMNs could explain the phenotypic variation that is such
a prominent feature of ALS.
Results
Distribution of mercury in the human CNS after exposure
to metallic mercury
1. Heavy and widespread mercury staining. This was
present in only two groups of neurons: (a). Locus
ceruleus (LC) neurons contained the heaviest
concentration of mercury in the brain. About 70% of
these neurons contained autometallography-
demonstrable mercury (HgAMG) grains, which were
widespread within the cytoplasm of affected cells
(Figure 1A). The small black HgAMG grains could
readily be distinguished from the larger pale brown
granules of neuromelanin. The total number of
neurons within the LC appeared normal, though no
formal quantitation was undertaken. (b). CMNs in
the frontal motor strip stood out clearly on AMG
staining because of the heavy concentration of
mercury in all visible CMNs (Figure 1B). No
adjacent smaller neurons, or large neurons in the
somatosensory cortex, contained HgAMG grains.
2. Heavy and patchy mercury staining. HgAMG grains
were seen in subependymal astrocytes adjacent to all
ventricles.
3. Light and widespread mercury staining. Capillaries in
all parts of the brain contained patchy mercury
staining, either in the wall itself or adjacent to the
wall (Figure 1C).
4. Light and patchy mercury staining. Light-patchy
HgAMG grains were seen in: (a) cerebellar dentate
nucleus neurons; (b) scattered individual neurons in
the brain stem reticular formation and
periaqueductal grey matter; and (c) neurons in the
hypothalamus, vestibular nucleus, and nucleus
intercalatus. Pineal and choroid plexus cells also
contained light-patchy HgAMG grains.
5. Glial cells. Scattered glial cells contained HgAMG
grains. These were not distributed evenly
throughout the brain, but were concentrated in the
frontal motor cortex (Figure 1B), red nucleus,
pallidum, caudoputamen, and cerebellar dentate
nucleus. The round, pale, nuclear morphology of the
cells suggested that most of these cells were
astrocytes. The mercury was situated adjacent to the
nucleus and not obviously in any processes.
AB
C
Figure 1 Mercury staining in human brain after exposure to
metallic mercury. (A) Mercury in locus ceruleus neurons is seen
as small black HgAMG grains, which can readily be distinguished
from the pale yellow-brown neuromelanin granules in the
cytoplasm. An occasional glial cell (arrow) contains a few HgAMG
grains. (B) The cytoplasm of this corticomotor neuron (thick arrow)
in the frontal motor cortex contains numerous HgAMG grains. Two
nearby small neurons (thin arrows) contain no mercury. The
cytoplasm of some glia (asterisks) contains mercury. (C) Mercury
staining is seen in the region of this capillary wall (arrow) in the
frontal motor cortex. No adjacent small neurons or glia contain
mercury. LFB-HgAMG, bar = 50 μm.
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nuclei of the brain stem, including the hypoglossal nu-
cleus (Figure 2A), in motor neurons in spinal lamina 9
down to the C3 level (Figure 2B), or in the substantia
nigra (including the neuromelanin-containing neurons).
In a non-mercury-exposed control 26 year-old male
individual no mercury staining was seen in neurons or
glia from any of the above regions.
Distribution of mercury in mouse CNS
The distribution of mercury in the CNS of mice that had
been exposed to either mercury vapor (Hg0) or mercuric
chloride (HgCl2) was similar to that previously described
in rodents [18-20]. In all mice, heavy widespread mer-
cury staining was seen in lamina 9 motor neurons in the
spinal grey matter (Figure 3A). All brain stem cranial
nerve motor neurons stained heavily with mercury, par-
ticularly the hypoglossal nucleus (Figure 3B) and nucleus
ambiguus, but also the extraocular muscle motor nuclei.
Slight patchy mercury staining was present in the dorsal
motor nucleus of the vagus nerve. Subependymal cells
stained prominently for mercury (Figure 3C). Scattered ca-
pillary walls contained HgAMG grains in mice sacrificed
7 days after mercury exposure (but not after longer times
after exposure), as did a few ependymal cells. No mercury
staining was seen in mouse LC neurons (Figure 3C) or in
neurons in somatomotor layers 3 or 5 (Figure 3D). No
mercury staining was seen in glial cells of the brain or
spinal cord in any mice.
Kidney mercury staining
1. Human. Heavy mercury staining was present in renal
tubules, but not in glomeruli, of the mercury-exposed
human (Figure 2C).
2. Mouse. Mercury staining was present in renal
tubules of mice sacrificed 7 days after exposure to
either HgCl2 or Hg
0, but not in mice sacrificed
705 days after HgCl2 exposure. To see if kidney
mercury might be transferred via the sympathetic
nervous system to CMNs in the same way as
rabies virus [21], sections from the
intermediolateral neurons in the thoracic spinal
cord and from the thoracic sympathetic chain
were stained with AMG. No intermediolateral
neurons, and only about 1% of sympathetic chain
neurons, contained light HgAMG staining.
Discussion
Mercury was deposited predominantly in CMN and LC
neurons of an individual who had injected himself with
metallic mercury. The heavy deposition of mercury in hu-
man LC neurons suggests that these cells play a part in the
selective uptake of inorganic mercury by CMNs, since
AB
C
Figure 2 Results of mercury staining in human lower motor
neurons and kidney after exposure to metallic mercury. (A) No
stainable mercury is present in hypoglossal motor neurons or in
nearby glia. LFB-HgAMG, bar = 50 μm. (B) No stainable mercury is
present in C3 anterior horn spinal motor neurons (arrows) or
surrounding glia. LFB-HgAMG, bar = 50 μm. (C) Heavy mercury
staining is present in renal tubules, but not in glomeruli (asterisks).
Hematoxylin-HgAMG, bar = 200 μm.
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tion of mercury differed from that seen in mice exposed to
inorganic mercury, where mercury was found in brain
stem and spinal motor neurons. This suggests either that
uptake of the toxin differs in humans and rodents, or that
differences in the chemical forms of this toxin, duration of
exposure to the toxin, or other factors that increase uptake
mechanisms of the toxin, result in the toxin being taken up
by different groups of motor neurons.
Uptake of metals by corticomotor neurons
Human
AMG has been used to study the distribution of inor-
ganic mercury in the brain of two other humans. The
first was a man aged 50 years at death who had
worked for 18 months filling mercury thermometers
before presenting 16 years later with tremor and dys-
arthria [12]. After his death mercury staining was seen
in some large neurons in the cerebral cortex, but
whether or not these were CMNs cannot be deter-
mined. The second individual was a man who had been
exposed to Hg0 for 13 years when he recycled mercury
from amalgams, with an acute exposure to Hg0 when
aged 41 years [13]. He had no specific symptoms of
mercury toxicity, and died in 1990 from lung cancer,
not having been at work for 16 years. He had wide-
spread neuronal mercury staining, but no mention of
mercury in CMNs was made. Therefore our case is the
only one in which human CMN mercury can confi-
dently be said to be present. In our dissection protocol,
the cerebral hemispheres are first cut in the horizontal
plane from the vertex for 40 mm, before the remainder
of the hemispheres are sectioned coronally [22]. This
allows us to obtain long strips of primary motor cortex
that contain large numbers of CMNs, which makes the
assessment of mercury distribution within these neu-
rons straightforward.
Animal
None of our mercury-exposed mice had stainable mercury
within their CMNs. CMN uptake of metals in other ani-
mal studies has varied. After mice were exposed to a large
dose of bismuth subnitrate, large cell bodies in the frontal
cortex (probably CMNs) stained positively with AMG
[23]. In rats given intraperitoneal HgCl2 a few cells in cor-
tical lamina 6 stained with AMG [18], but no cortical
staining was seen in rats given oral HgCl2 [24]. Mercury-
sensitive SJL/N mice exposed long-term to Hg0 had stain-
able mercury in neocortical layer 5 [25], unlike short-term
Hg0 exposure of non-mercury sensitive Wistar rats where
staining was in layer 3 [19]; this suggests that genetic
background and length of mercury exposure may influ-
ence which neocortical cells take up inorganic mercury. In
squirrel monkeys exposed to a large dose of Hg0, the giant
BA
DC
Figure 3 Mercury staining in mouse spinal cord and brain after exposure to mercury. (A) After Hg0 exposure, all large spinal motor
neurons in the cervical spinal cord contain HgAMG grains. No glial staining is seen. (B) After Hg0 exposure, all large hypoglossal motor neurons
contain HgAMG grains. No glial staining is seen. (C) After Hg0 exposure, dense HgAMG grains are seen in subependymal astrocytes near the
ventricle (V), but no locus ceruleus neurons (outlined) contain mercury. (D) After mercuric chloride exposure, no mercury staining is present in
layer 5 somatomotor neurons in the frontal lobe, or in surrounding glial cells. Hematoxylin-HgAMG, bar = 50 μm.
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mercury than other neurons, though neuronal uptake was
widespread at these doses [26].
Differences between mouse and human CMNs could
underlie the lack of mercury uptake in mouse CMNs.
Mice do not have a subpopulation of very large CMNs
that are the equivalent of human Betz cells, and mouse
CMNs do not make direct synaptic contact with LMNs
as is the case with humans [27]. Mice may not be
subjected to the long-term stressors that humans experi-
ence, and so may not be prone to take up toxins via the
locus ceruleus pathway (see later). The resistance of ro-
dent CMNs to toxin uptake could be one reason that ro-
dent models of ALS have a relatively poor track record
when it comes to translating therapeutic trials from ro-
dents to humans [28].Uptake of metals by locus ceruleus neurons
Human
The two previous AMG studies on mercury-exposed
humans do not mention whether or not the LC contained
mercury [12,13]. It is therefore only our case in which mer-
cury uptake in the LC has been demonstrated. One reason
for this may be that our individual would have been under
considerable stress, and this may have prompted mercury
uptake into CMNs via the LC (see below).
Animal
We did not see any LC uptake of mercury in our
mercury-exposed mice. The only report of uptake of a
metal by the LC in rodents was a scanty uptake after
mice were given a large toxicity-inducing dose of intra-
peritoneal bismuth subnitrate [23]. After this large dose
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5 of the frontal and parietal cortex, contained this metal
[23]. LC neuronal uptake was not mentioned in rats
given intraperitoneal HgCl2 [18], rats given oral HgCl2
[24], rats exposed to Hg0 [19], or mice exposed to Hg0
[25]. In most of these reports the LC was not mentioned,
which may be because it contained none of the metal or
because this is very small nucleus in rodents and can
easily be overlooked. Rats exposed to a very high dose of
Hg0 did have mercury in their LC, but with this high cir-
culating level of mercury neuronal uptake was wide-
spread [29]. In a report of mercury-exposed primate
CNS that was examined with AMG the LC was not
mentioned [30].
Uptake of metals by glia
Human
In one previous mercury-exposed human, HgAMG stain-
ing was seen in astrocytes, but the distribution of these
astrocytes was not given [12]. In our case, astrocytes in
various sites contained mercury. There did not appear to
be any particular pattern to this distribution, and the re-
lationship between mercury-containing glia and neurons
was weak. The only region where mercury-containing
glia were consistently found adjacent to mercury-
containing neurons was in the frontal motor cortex: here
all mercury-containing CMNs had nearby astrocytes that
also contained mercury. Astrocytes appear to have different
domains within the CNS [31] so some groups of astrocytes
may have more of a propensity to take up metals than
others. However, it seems more likely that these mercury-
astrocytes are attempting to lower the mercury burden of
the CMNs by removing some of the metal from these neu-
rons [12,17]. If this is the case, the CMN lays itself open to
being subject to a perverse toxic-gain-of-function if the
mercury in the astrocyte then causes an excitotoxic insult
to the CMN via excess glutamate [32-34] or via the onset
of neuroinflammation [35]. Finally, it is possible mercury is
moving in the opposite direction, with astrocytes transfer-
ring mercury they have taken up from blood vessels to
CMNs. The exact role of glial heavy metals in human
neurotoxicology is thus not yet clear.
Animal
Uptake of metals by rodent astrocytes and microglia
has been noted to be much less prominent than uptake
into primate and human glia [17]. We too found this to
be the case in our mice exposed to HgCl2 or Hg
0 since
no glia in the CNS contained significant amounts of
mercury. This may explain why rodents appear to be
relatively resistant to the major neurotoxic effects of in-
organic mercury [36], since there would be no mercury
in astrocytes to provoke a glutamate-induced excitotoxic
attack on nearby neurons [34].Routes of metal transport into corticomotor neurons
Via the locus ceruleus
The LC has a potential exposure to circulating toxins
through its extensive innervation of CNS blood vessels,
and has extensive collateral axonal innervation to many
CNS neurons, including CMNs [37]. Although a route
for mercury from intracerebral blood vessels via the LC
to CMNs has not yet been proven experimentally, a po-
tential pathway would be: (1) metallic mercury in tissues
releases Hg0 which is converted into Hg2+ [38]; (2) Hg2+
enters the circulation and is bound to thiol-containing
molecules such as cysteine [39]; (3) the Hg2+-thiol com-
plexes in the region of capillaries are taken up at LC axon
terminals, probably by some form of molecular mimicry.
This could be by using the re-uptake of noradrenaline
(NA) into LC terminals through the norepinephrine
transporter, since NA axon terminals are intimately asso-
ciated with intraparenchymal blood vessels [40]; (4) the
Hg2+-thiol complex enters the axon of the LC and is
transported via retrograde axonal transport towards the
cell body; (5) some Hg2+ remains in the LC cell body, but
some is transferred via anterograde axonal transport to
the LC axons that terminate at the CMN. Anterograde
metal transport has been described for a variety of metal
[41]; (6) the Hg2+-thiol complex is released at the LC
axon’s CMN terminal, either at typical synapses, or at
non-synaptic release sites in the vicinity of the CMN
[42]; (7) the Hg2+-thiol complexes are transported into
the CMN, possibly by molecular mimicry involving a ves-
icular transporter [43] or because cysteine is taken up
avidly by neurons to form glutathione [44]. The other
major form of toxic metal transport, ionic mimicry, is less
likely to occur with Hg2+ since in biological systems Hg2+
is usually bound to thiol-containing molecules [42].
Stressors (stimuli that disrupt homeostasis) can be di-
vided into those that are physical, psychological, social,
and those that disrupt cardiovascular or metabolic
homeostasis [37]. NA output from the LC of animals in-
creases markedly after exposure to a large number of dif-
ferent stressors, such as cold, restraint, electric shocks,
chronic social stress, and forced walking [45]. If inorganic
mercury enters CMNs via the re-uptake of NA into
the LC, it is likely that this stressor-activated path-
way deposits a large amount of mercury into CMNs
(Figure 4B), more than can be detoxified by binding to
metallothionein [38]. Our patient committed suicide,
and although we do not have details of his state of
mind in the weeks leading up to his death, it is to be
expected that he would have been under considerable
psychological stress. So of relevance is the finding that,
compared to 11 controls, 6 suicide victims had fewer
neurons in their LC when these were quantitated at
post mortem examination [46]. This would be expected






































Figure 4 Potential pathways for toxins to enter motor neurons and the possible resulting ALS phenotypes. (A) This circulating toxin is
taken up from cerebral (but not peripheral) blood vessels and enters LC neurons. The LC neurons then pass the toxin on to CMNs (thin dashed
arrow). With low levels of stress, CMNs take up only a small amount of the toxin, which can readily be handled by cellular detoxifying
mechanisms. (B) Under high levels of stress, increased noradrenaline recycling in LC neurons leads to a greater uptake of the toxin into CMNs,
which overwhelms the cellular detoxifying mechanisms and could cause an upper motor neuron predominant form of ALS. A toxin that causes
CMNs to produce more glutamate will damage LMNs, possibly leading to classical ALS. (C) During strenuous exercise an increased uptake of
circulating toxin from intramuscular blood vessels at neuromuscular junctions damages LMNs. This could result in a lower motor neuron
predominant form of ALS. (D) This toxin, aided by both stress and exercise, is taken up from both cerebral and intramuscular blood vessels and
so can enter CMNs and LMNs. This could result in classical ALS. BVc: cerebral blood vessel, BVm: intramuscular blood vessel, CMN: corticomotor
neuron, Glut: glutamate, HgAMG: autometallographic-demonstrable mercury, LC: locus ceruleus, LFB: Luxol-fast blue, Mus: muscle.
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age these neurons.
A stressor-induced increased toxin uptake into CMNs
could explain the conundrum concerning the increased in-
cidence of SALS in military personnel. Three studies of
SALS in the US military, all using different methodologies,
have reported a doubling of SALS incidence after
military service [47-49]. One of these showed that
military personnel who saw active (and presumably
stressful) service had an increased risk of SALS com-
pared to those who did not [48]. Of interest, all divi-
sions of the military (army, navy and air force) had a
increased risk of SALS, despite being engaged in differ-
ent duties, suggesting some common factor underlay
the increased risk of SALS. Although two of the studies
involved Gulf war veterans [47,48], the third looked at
servicemen before 1990 [49], which suggests that SALS
risk is not related to any particular war zone, but to the
experience of war itself. This led to criticism that such
studies are unlikely to find any particular toxic agent
responsible for the increased risk of SALS [50]. How-
ever, one thing these military personnel would have had
in common is increased stress, with concomitant LC
activation and the potential to take up any circulating
neurotoxins that were present during the time of stress,
which could then enter CMNs. Of note, decreased
numbers of neurons in the LC have been reported in
military personnel with post-traumatic stress disorder,
a finding which would be expected if stress were pro-
moting the uptake of toxins into this nucleus [51].
Epidemiological studies have identified a number of oc-
cupations which appear to be associated with an increased
risk of SALS [8]. A large number of these occupations are
stressful, such as truck drivers [52,53], airline pilots [54],
and professional athletes and sportsmen such as soccer
players [55]. One study has suggested an increased risk of
SALS associated with self-reported stress [56], though an-
other showed that the death of a child had no effect on the
later risk of SALS [57]. It remains to be determined
whether people who go on to have SALS have been
subjected to increased stress at the same time that they
have been exposed to environmental neurotoxins.
Via astrocytes
The possibility that astrocytes could take up metals from
blood vessels and pass them on CMNs has been men-
tioned above.
Via the kidney
Recently it was shown that replicating viruses injected
into mouse kidney can be transferred to CMNs via a
chain of sympathetic neurons [21]. However, in our
mercury-exposed mice no or very small amounts of
mercury could be seen in sympathetic ganglia, and nonewas present in intermediolateral neurons, so mercury
seems unlikely to use this route to reach CMNs.
Via lower motor neurons
CMNs make direct connections with LMNs in higher
primates [27], and theoretically a toxic metal could pass
between the two, as has been shown for tetanus toxin
[58]. However, no significant mercury staining was seen
in LMNs in our human case, so it seems unlikely that
transfer of mercury from lower to upper motor neurons
took place in this individual.
Uptake and routes of metal transport into lower motor
neurons
Animal
In our mice exposed to Hg0 or HgCl2+ mercury was
found in LMNs but not in CMNs. Uptake of toxic metals
into LMNs has been well studied in rodents [41]. The
pathway appears to be from circulating blood into stri-
ated muscle, from where the metals are taken up at the
neuromuscular junction, either via calcium channels in
the case of lead [59] or by recycling vesicles [60]. From
the axon terminal the metals are retrogradely transported
to the LMN cell body [41].
Human
Our mercury-exposed human had no significant mercury
in his LMNs, unlike the two previously reported human
cases, both of whom had mercury in their spinal and brain
stem motor neurons [12,13]. This could be because in our
case the time between mercury exposure and death was
only a few weeks, compared to the other two cases where
this time was a number of years. These two cases would
therefore have had considerably more time for mercury to
be transported from their neuromuscular junctions to their
LMNs. We do not know how physically active our individ-
ual was between his injection of mercury and death
5 months later. However, a period of relative inactivity
might explain the lack of mercury in his LMNs. Exercise
induces hypertrophy of the neuromuscular junction [61]
and enhances neuromuscular transmission across the junc-
tion [62], both of which would facilitate toxin transfer into
LMNs via the neuromuscular junction. A number of stud-
ies have reported that previous episodes of intense physical
activity are associated with a greater susceptibility to ALS
later in life [55,63-66]. This may be because exercise
increases the chance of “suicide transport” [67] of circula-
ting toxins into LMNs.
Variations in the amount of toxins in motor neurons and
different ALS phenotypes
Uptake of circulating toxins can vary between CMNs
and LMNs for a number of reasons: (a) CNS blood ves-
sels with tight junctions and peripheral vessels without
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(b) different recycling mechanisms at axon terminals (e.g.,
noradrenaline in LC neurons and acetylcholine in LMNs)
could favor certain toxins; (c) some toxins could enter as-
trocytes adjacent to CNS blood vessels and their absence
at the neuromuscular junction means that toxin could not
enter via this route; (d) different physiological stimuli
upregulate recycling mechanisms differently, e.g., stress
upregulates LC neuron noradrenalin recycling and exercise
upregulates acetylcholine recycling.
Toxins entering CMNs selectively: primary lateral sclerosis
or ALS
A toxin taken up from CNS blood vessels by the LC would
preferentially enter CMNs (Figure 4B). This would be en-
hanced by stressor upregulation of LC activity, which could
pump more circulating toxin into CMNs. This surge of
toxin could overcome the cell’s defence mechanisms and
cause one of the many pathogenetic alterations described in
heavy metal toxicity, in addition to protein misfolding. If
only CMN damage occurred, the upper motor neuron form
of ALS (primary lateral sclerosis) could result. However, if
the toxin caused the CMN to produce more glutamate at
its synapse with the LMN (possibly by astrocyte mercury
exciting the CMN) the LMN could suffer excitotoxic death,
resulting in a classical ALS phenotype. Compelling argu-
ments have been put forward that ALS can be caused by
cortical hyperexcitability [68] and recent neurophysiological
evidence supports this concept [69].
Toxins entering LMNs selectively: progressive muscular atrophy
A circulating toxin that entered the LMN via the
neuromuscular junction, possibly enhanced by increased
exercise, could poison the LMN and result in the LMN-
predominant form of ALS, progressive muscular atrophy
(Figure 4C).
Toxins entering both CMNs and LMNs: ALS
A circulating toxin that was able to use both the CMN
and LMN routes of entry (possibly aided by both stress
and exercise) could poison both sets of neurons and re-
sult in an ALS phenotype (Figure 4D).
Although we have considered these phenotypic varia-
tions as they relate to SALS, in familial ALS marked varia-
tions also occur in the distribution of weakness and age of
disease onset in different family members. In addition to
gene-gene interactions, it is possible that having a variable
toxin load in different sets of motor neurons makes these
neurons differentially susceptible to ALS-associated genetic
mutations.
Conclusion
In conclusion, we have described the unique case of a
man who would have been under psychological stressat the same time as he was exposed to inorganic mer-
cury. At post mortem mercury was present in CMNs
and LC neurons. We suggest that stress-related
upregulation of LC neurons enabled large amounts of
circulating mercury to be shunted into CMNs. While
we have focused on heavy metal uptake, a range of
environmental neurotoxins could just as readily use
this “toxin-stress” pathway to enter CMNs. We have
further shown differences between this human CMN
uptake of toxin and the rodent uptake of circulating
toxins into LMNs, which could be increased by exer-
cise. Because ALS probably begins some years before
symptoms become apparent, any search for environ-
mental toxins that underlie the disease need to take
into account life-long exposures. Finally, we suggest
that phenotypic variations in both sporadic and famil-
ial ALS may be due to different amounts of toxins in
upper and lower motor neurons.
Methods
Human exposed to metallic mercury
The detailed clinical information on this individual has
been described previously [14]. Briefly, a 24 year-old
man injected metallic mercury into his antecubital vein,
from which he suffered no apparent ill effects, consist-
ent with other cases of metallic mercury self-injection
[70]. Five months later he died after committing suicide
by lacerating both his wrists. At post mortem examin-
ation metallic mercury globules were present in his
myocardium and lungs, but not in the brain. Tissue
blocks were processed routinely for paraffin sections.
For the present study, further 7 μm sections were cut
from all available paraffin blocks (including those not
stained in the previous study) of the cerebrum, cerebel-
lum, brain stem, upper cervical cord and kidney. Paraf-
fin sections from the same regions of a 26-year-old
man who died from complications of cystic fibrosis
were used as a control.
Mice exposed to mercuric chloride or mercury vapor
6-week-old BALB/c mice (four per group) had been ex-
posed previously to either: (a) a single dose of 2 μg/g in-
traperitoneal HgCl2, with sacrifice either 7 or 705 days
later; (b) either 50 μg/m3 or 500 μg/m3 Hg0 for 4 h a
day for 6 days, with sacrifice 7 days later. Control mice
were given either an intraperitoneal saline injection or
placed in the exposure chamber without Hg0 flow
[36,71]. For the present study, further 7 μm sections of
formalin-fixed paraffin-embedded blocks of brain, spinal
cord and kidney were cut and stained for mercury, using
the same protocol as for the human sections. Where ne-
cessary, further sections were cut to locate regions, for
example the LC and sympathetic ganglia, that were not
previously studied.
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Tissue was stained for mercury using AMG [15]. Briefly,
paraffin sections were placed in physical developer
containing 50% gum arabic, citrate buffer, hydroquinone
and silver nitrate at 26°C for 80 min in the dark, then
washed in 5% sodium thiosulphate to remove unbound sil-
ver. Sections were counterstained with either hematoxylin
or Luxol-fast blue and viewed under bright-field illumin-
ation. Silver-coated mercury deposits are referred to as
autometallography-demonstrable mercury (HgAMG). In
each staining run, a positive control section was included
which contained mouse spinal motor neurons with known
mercury deposits from a previous intraperitoneal injection
of HgCl2.
Mercury staining within individual neurons was con-
sidered to be “heavy” if more than 10 HgAMG grains
were seen, “light” if 3–10 grains were seen, and “absent”
if fewer than 3 grains were seen. Mercury staining was
considered to be “widespread” if more than 40% of neu-
rons of the same type or within the same nucleus
contained HgAMG grains, and “patchy” if 40% or fewer of
these cells contained HgAMG grains. Mercury staining
was considered to be present in glial cells if 2 or more
HgAMG grains were seen in the cell.
The anatomical nomenclature used (for both human and
mice neuroanatomy) was from the Allen Mouse Brain
(http://mouse.brain-map.org.) and Spinal Cord (http://
mousespinal.brain-map.org.) online atlases. The protocol
for the human part of the study was approved by the
Human Ethics Committee of the Sydney South West Area
Health Service, and the animal protocol was approved by
the University of Sydney Animal Ethics Committee.
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